APA
Alshahrani M. S., Asonto L. P., El Tahan M. M., Al Sulaibikh A. H., Al Faraj S. Z., Al Mulhim A. A., Al Abbad M. F., Al Nahhash S. A., Aldarweesh M. N., Mahmoud A. M., Almaghraby N., Al Jumaan M. A., Al Junaid T. O., Al Hawaj F. M., AlKenany S., ElSayed O. F., Abdelwahab H. M., Moussa M. M., Alossaimi B. K., Alotaibi S. K., AlMutairi T. M., AlSulaiman D. A., Al Shahrani S. D., Alfaraj D. & Alhazzani W. (20191223). Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease. : Trials.
Chicago
Alshahrani Mohammed S, Asonto Laila Perlas, El Tahan Mohamed M, Al Sulaibikh Amal H, Al Faraj Sukayna Z, Al Mulhim Abdullah A, Al Abbad Murad F, Al Nahhash Samar A, Aldarweesh Moath N, Mahmoud Alaa M, Almaghraby Nisreen, Al Jumaan Mohammed A, Al Junaid Thamir O, Al Hawaj Faisal M, AlKenany Samar, ElSayed Omaima F, Abdelwahab Haitham M, Moussa Mohamed M, Alossaimi Bader K, Alotaibi Shaikah K, AlMutairi Talal M, AlSulaiman Duaa A, Al Shahrani Saad D, Alfaraj Donia and Alhazzani Waleed. 20191223. Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease. : Trials.
Harvard
Alshahrani M. S., Asonto L. P., El Tahan M. M., Al Sulaibikh A. H., Al Faraj S. Z., Al Mulhim A. A., Al Abbad M. F., Al Nahhash S. A., Aldarweesh M. N., Mahmoud A. M., Almaghraby N., Al Jumaan M. A., Al Junaid T. O., Al Hawaj F. M., AlKenany S., ElSayed O. F., Abdelwahab H. M., Moussa M. M., Alossaimi B. K., Alotaibi S. K., AlMutairi T. M., AlSulaiman D. A., Al Shahrani S. D., Alfaraj D. and Alhazzani W. (20191223). Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease. : Trials.
MLA
Alshahrani Mohammed S, Asonto Laila Perlas, El Tahan Mohamed M, Al Sulaibikh Amal H, Al Faraj Sukayna Z, Al Mulhim Abdullah A, Al Abbad Murad F, Al Nahhash Samar A, Aldarweesh Moath N, Mahmoud Alaa M, Almaghraby Nisreen, Al Jumaan Mohammed A, Al Junaid Thamir O, Al Hawaj Faisal M, AlKenany Samar, ElSayed Omaima F, Abdelwahab Haitham M, Moussa Mohamed M, Alossaimi Bader K, Alotaibi Shaikah K, AlMutairi Talal M, AlSulaiman Duaa A, Al Shahrani Saad D, Alfaraj Donia and Alhazzani Waleed. Study protocol for a randomized, blinded, controlled trial of ketamine for acute painful crisis of sickle cell disease. : Trials. 20191223.